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Abstract Naive B cells co-express two BCR isotypes, IgM and IgD, with identical antigen-binding
domains but distinct constant regions. IgM but not IgD is downregulated on autoreactive B cells.
Because these isotypes are presumed to be redundant, it is unknown how this could impose
tolerance. We introduced the Nur77-eGFP reporter of BCR signaling into mice that express each
BCR isotype alone. Despite signaling strongly in vitro, IgD is less sensitive than IgM to endogenous
antigen in vivo and developmental fate decisions are skewed accordingly. IgD-only Lyn /  B cells
cannot generate autoantibodies and short-lived plasma cells (SLPCs) in vivo, a fate thought to be
driven by intense BCR signaling induced by endogenous antigens. Similarly, IgD-only B cells
generate normal germinal center, but impaired IgG1+ SLPC responses to T-dependent
immunization. We propose a role for IgD in maintaining the quiescence of autoreactive B cells and
restricting their differentiation into autoantibody secreting cells.
DOI: https://doi.org/10.7554/eLife.35074.001
Introduction
The pre-immune mature naı¨ve B cell compartment must balance the need for a diverse antibody rep-
ertoire with the risk of autoantibody-mediated disease. Early in development, B cells randomly rear-
range their immunoglobulin genes through VDJ recombination and encounter a series of tolerance
checkpoints that serve to remove autoreactive B cell receptors (BCRs) from the repertoire. Strongly
autoreactive immature B cells rearrange additional light chains to ‘edit’ their autoreactivity, and they
ultimately undergo deletion if this is unsuccessful (Shlomchik, 2008). Yet, despite stringent counter-
selection of autoreactivity, the mature follicular (Fo) B cell compartment retains cells reactive towards
endogenous antigens (Wardemann et al., 2003; Zikherman et al., 2012). How these cells are
restrained from mounting autoimmune responses is not fully understood.
We previously described a BAC Tg reporter mouse (Nur77-eGFP) in which GFP expression is
under the control of the regulatory region of Nr4a1, an immediate early gene rapidly induced by
antigen receptor signaling (Mittelstadt and DeFranco, 1993; Winoto and Littman, 2002). We
showed that Nur77-eGFP expression in naı¨ve B cells is proportional to strength of antigenic
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stimulation and consequently to autoreactivity (Zikherman et al., 2012). The most prominent charac-
teristic of GFPhi reporter B cells is decreased surface IgM BCR relative to GFPlo cells. Goodnow and
colleagues first suggested that IgM downregulation may mark autoreactive B cells in the normal
mature repertoire shortly after they reported selective downregulation of IgM in the IgHEL (hen egg
lysozyme) BCR Tg/soluble HEL Tg model system of B cell autoreactivity (Goodnow et al., 1988;
Goodnow et al., 1989). Indeed, multiple studies in mice and humans have identified naturally occur-
ring IgD+IgMlo cells as autoreactive and ‘anergic’ or functionally unresponsive (Duty et al., 2009;
Kirchenbaum et al., 2014; Qua´ch et al., 2011; Zikherman et al., 2012). These results corroborate
observations with several BCR transgenic model systems (Cambier et al., 2007). However, whether
or how IgM downregulation might constrain autoreactivity remains unclear because naturally-occur-
ring autoreactive B cells maintain high expression of the IgD BCR isotype (Zikherman et al., 2012).
IgM and IgD are splice isoforms of a common precursor heavy chain mRNA (Moore et al., 1981).
While they differ in their Fc domains, both BCR isotypes contain the same antigen-binding domain,
as well as identical 3-amino acid cytoplasmic tails, and they pair with Iga/b in order to initiate the
canonical BCR signaling cascade (Blum et al., 1993; Radaev et al., 2010). However, the expression
pattern of the isotypes differs; IgM expression begins as soon as heavy and light chains recombine
early in B cell development, and persists until class switch recombination occurs following B cell acti-
vation (Chen and Cerutti, 2010). IgD is uniquely co-expressed with IgM during a narrow develop-
mental window on late transitional and mature naı¨ve Fo B cells as a result of alternate splicing
regulated by the zinc-finger protein ZFP318 (Enders et al., 2014; Pioli et al., 2014). This suggests
that IgD may play a critical role specifically in mature naı¨ve B cells. Initial characterization of IgM-
and IgD-deficient mice revealed only mild phenotypes and substantial redundancy; each isotype
could mediate B cell development, initiate antibody responses to T-dependent and -independent
immunization, and induce normal levels of steady-state serum IgG (Lutz et al., 1998;
Nitschke et al., 1993; Roes and Rajewsky, 1993). This is consistent with prior studies in BCR
eLife digest To defend an organism against invaders such as viruses and bacteria, cells of the
immune system need to recognize and respond to foreign microbes. However, these immune cells
must also avoid attacking ‘self’ – for example, the healthy tissues of the body – as this could lead to
autoimmune disease.
B cells are a type of immune cell that is essential in order to produce antibodies, protective
proteins that can identify and defend against a broad range of germs: in addition, certain antibodies
can also recognize ‘self’. When a B cell first develops, it places its antibody on its surface and uses
this protein as a receptor (termed ‘B cell receptor’) to sense its surroundings.
Prior to mounting an immune response, B cells carry two closely related versions of the B cell
receptor on their surface: IgM and IgD. Both IgM and IgD perform many of the same roles and can
largely substitute for one another. However, B cells that recognize ‘self’ decrease their levels of IgM
but keep high amounts of IgD on their surface. It is unclear why this is the case, but one possibility is
that IgM and IgD may see ‘self’ differently.
To investigate this, Noviski et al. used mice with B cells that only carry either IgM or IgD, and
tracked how these cells reacted to molecules from ‘self’ and foreign origins. IgM-only B cells reacted
more strongly to ‘self’ molecules than IgD-only cells, which suggests that IgM is more sensitive to
‘self’ than IgD. In fact, in mice which are at risk for an autoimmune disease similar to lupus, deleting
the IgM receptor prevented antibodies against ‘self’ from being produced. Therefore, reducing the
amount of IgM receptors may be a way to keep B cells that are reactive against ‘self’ from
inappropriately attacking the host. Meanwhile, the IgD receptor still allows B cells to mount
protective antibody responses against foreign microbes.
Future studies are necessary to determine whether these differences between IgM and IgD also
exist in humans. If this is the case, blocking the IgM receptor could become a new kind of treatment
for certain autoimmune diseases.
DOI: https://doi.org/10.7554/eLife.35074.002
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transgenic model systems demonstrating that each isotype alone can mediate B cell development,
deletion, and activation (Brink et al., 1992).
IgM and IgD differ structurally; IgD has a much longer, flexible hinge region linking its Fab and Fc
regions than IgM does (Chen and Cerutti, 2010). Recently, Ubelhart, Jumaa, and colleagues dem-
onstrated that a short and inflexible hinge confers upon IgM the unique capacity to signal in
response to monovalent antigens, while both isotypes can respond to multivalent antigens
(U¨belhart et al., 2015). However, the Goodnow lab subsequently showed that IgHEL Tg splenic B
cells expressing either the IgD or IgM BCR exclusively could mobilize calcium in response to soluble
HEL antigen in vitro, and each isotype can mediate a common gene expression program characteris-
tic of anergy in vivo (Sabouri et al., 2016). Therefore, it remains unclear whether IgM and IgD BCRs
expressed in an unrestricted B cell repertoire differentially sense bona fide endogenous antigens in
vivo, particularly as the identity and nature of such antigens is largely unknown and not restricted to
soluble monovalent antigens. For example, 5–10% of circulating naı¨ve B cells in healthy humans
express the well-characterized unmutated and autoreactive human heavy chain V-segment IGHV4-
34, and these cells exhibit anergy, selective IgM downregulation, and recognize cell-surface antigens
on erythrocytes and B cells in vivo (Qua´ch et al., 2011; Reed et al., 2016).
We and others previously hypothesized that downregulation of IgM on Fo B cells might serve to
restrain their response to endogenous antigen. Conversely, high expression of IgD on these cells
might play a ‘tolerogenic’ role (Zikherman et al., 2012). To determine how IgM and IgD differen-
tially regulate B cell responses to endogenous antigens, we generated Nur77-eGFP reporter mice
deficient for either IgM or IgD (Lutz et al., 1998; Nitschke et al., 1993). Using this reporter of anti-
gen-dependent signaling, we show that IgD is less sensitive than IgM to bona fide endogenous anti-
gens in vivo despite higher surface expression and robust responsiveness to receptor ligation in
vitro. Indeed, marginal zone (MZ) and B1a cells that express IgD but lack IgM induce less Nur77-
eGFP than WT, and this is not attributable to repertoire differences. To further support these obser-
vations, we examine a series of cell fate decisions for which in vivo BCR signaling requirements have
been previously defined. We show that IgD drives a pattern of development consistent with reduced
endogenous antigen recognition, favoring MZ B cell fate and disfavoring B1a cell fate. Similarly, IgD
alone is less efficient than IgM at driving SLPC expansion in response to endogenous antigens, a
process that requires robust BCR signaling. However, IgD is sufficient for germinal center (GC) B cell
differentiation. Our data suggest that reduced endogenous antigen sensing (i.e. signal transduction
in response to antigen binding) by the IgD BCR isotype shunts autoreactive IgDhi IgMlo Fo B cells
away from differentiation into SLPCs. We propose that predominant IgD expression maintains the
quiescence of autoreactive B cells in response to chronic endogenous antigen stimulation, and limits
autoantibody secretion in the context of rapid immune responses.
Results
Endogenous antigen is both necessary and sufficient for expression of
Nur77-eGFP reporter in B cells in vivo
We previously showed that antigen recognition was both necessary and sufficient for Nur77-eGFP
reporter expression by B cells in vivo (Figure 1A)(Zikherman et al., 2012). Thus, reporter expression
reflects endogenous antigen recognition in vivo. Conversely, under steady-state conditions in vivo,
the Nur77-eGFP reporter does not reflect signaling through other receptors expressed in B cells;
indeed, loss of either CD40, or TLR3, 7, and 9 signaling has no effect on reporter expression in B
cells in vivo (Figure 1—figure supplement 1A). Moreover, neither BAFF, nor IL-4, nor CXCR4-
dependent signaling can regulate reporter expression in vitro (Figure 1—figure supplement 1B–C)
(Zikherman et al., 2012). To further confirm that Nur77 expression in naı¨ve B cells under steady
state conditions is not regulated by microbial stimulation of pattern recognition receptors (e.g. TLRs
1, 2, 4, 6, and the TLR-4-like molecule RP105), we studied mice raised under either germ-free condi-
tions or conventional specific-pathogen-free conditions. We observed no induction of endogenous
Nur77 protein in splenic B cells or endogenous Nr4a1 transcript in splenocytes in the presence of
commensal flora (Figure 1—figure supplement 1D,E). Moreover, MyD88-deficient and MyD88-suffi-
cient splenocytes and peritoneal B1a cells express comparable amounts of endogenous Nr4a1 tran-
script and protein respectively under steady state conditions (Figure 1—figure supplement 1F,G).
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Figure 1. IgD expression enables a dynamic range of IgM responsiveness. (A) GFP expression in mature Fo
splenic B cells (CD19+CD23+CD93-) from Nur77-eGFP BAC Tg reporter mice with either a wild-type BCR
repertoire (left), or harboring IgHEL Tg specific for the cognate antigen HEL (hen egg lysozyme) in the absence
(middle), or presence (right) of endogenous cognate antigen driven by soluble HEL Tg. WT Fo B cells lacking GFP
reporter are included for reference (gray shaded histograms). (B) Surface IgM and IgD expression in splenic Fo B
cells from WT, IgM / , and IgD /  mice expressing the Nur77-eGFP reporter. (C) Splenocytes from WT, IgM / ,
and IgD /  mice were loaded with Indo-1 and stimulated with 2.5 mg/mL of F(ab’)2 anti-IgM or 1:400 anti-IgD. Fo
B cells with the highest 20% and lowest 20% Nur77-eGFP expression are compared. (D) Representative histograms
and quantification of surface Igk expression in IgM /  and IgD /  Fo B cells normalized to WT. (E) Representative
histograms and quantification of Nur77-eGFP expression in IgM /  and IgD /  Fo B cells normalized to WT. (F)
Median surface Igk expression of WT, IgM / , and IgD /  Fo B cells was calculated for 200 bins of equal width
across the Nur77-eGFP spectrum. For (A), (B) and (F), data are representative of at least n = 4 independent
experiments. For (C), n = 3 independent experiments for anti-IgM and n = 2 independent experiments for anti-
IgD. For (D) and (E), n = 7 and n = 4, respectively, WT, IgM / , and IgD /  mice. Welch’s t test was used to
calculate p values, and mean +SEM is displayed. ***p<0.001.
DOI: https://doi.org/10.7554/eLife.35074.003
The following source data and figure supplements are available for figure 1:
Source data 1. Numerical data corresponding to receptor and Nur77 reporter, protein and transcript levels in
Figure 1D–F and Figure 1—figure supplement 1D-G, 2B-E.
Figure 1 continued on next page
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Taken together, these data demonstrate that Nur77-eGFP expression in B cells under steady-state
conditions in vivo is a specific readout of antigen-dependent signaling through the BCR (Table 1).
We therefore sought to take advantage of the Nur77-eGFP reporter in order to probe the respon-
siveness of a diverse BCR repertoire of mature B cells expressing either IgM or IgD alone to the vast
range of endogenous antigens they may encounter in vivo.
Figure 1 continued
DOI: https://doi.org/10.7554/eLife.35074.007
Source data 2. Numerical data corresponding to receptor levels in Figure 1D.
DOI: https://doi.org/10.7554/eLife.35074.008
Source data 3. Numerical data corresponding to Nur77-eGFP levels in Figure 1E.
DOI: https://doi.org/10.7554/eLife.35074.009
Figure supplement 1. Regulation of endogenous Nur77 and Nur77-eGFP reporter expression.
DOI: https://doi.org/10.7554/eLife.35074.004
Figure supplement 2. Quantification of surface BCR expression on B cell subsets.
DOI: https://doi.org/10.7554/eLife.35074.005
Figure supplement 3. Induction of Nur77-eGFP and CD69 in TLR-stimulated IgM /  and IgD /  B cells.
DOI: https://doi.org/10.7554/eLife.35074.006
Table 1. Nur77-eGFP is a specific reporter of antigen-dependent signaling in vivo.
Conclusion
Stimulus/
perturbation Pathway Readout Cell type References
Does not modulate Nur77 at steady
state in vivo
CD40L-/- CD40 Nur77-eGFP B cells Manuscript Figure 1—figure supplement 1A
TLR7-/- TLR7 Nur77-eGFP B cells Manuscript Figure 1—figure supplement 1A
Un93b13d/3d TLR3/7/9 Nur77-eGFP B cells Manuscript Figure 1—figure supplement 1A
MyD88fl/fl
MB1-Cre
MyD88 Endog. Nur77
protein/transcript
PerC B1a
cells/spleen
Manuscript Figure 1—figure supplement 1F,G
Germ-free
mice
MyD88/
TRIF
Endog. Nur77
protein/transcript
Splenic B
cells/spleen
Manuscript Figure 1—figure supplement 1D,E
Const. act.
STAT5
Jak/Stat Nur77-eGFP Thymocytes Moran et al. JEM 2011, Figure 8.
Does not induce Nur77 in vitro BAFF BAFFR Nur77-eGFP B cells Zikherman et al. (2012): Figure S1G
IL-4 Jak/Stat Nur77-eGFP B cells Manuscript Figure 1—figure supplement 1B
IL-2, IL-15 Jak/Stat Nur77-eGFP CD8 (IL-2, 15),
CD4 (IL-2)
Au-Yeung et al. JI 2017, Figures S1A, 3C, 4A
CXCL12/
SDF-1
CXCR4 Nur77-eGFP B cells Manuscript Figure 1—figure supplement 1C
Induces Nur77 in vitro but does not
require IgM or IgD specifically
LPS TLR4,
Rp150
Nur77-eGFP B cells Zikherman et al. (2012): Figure S1G; Manuscript
Figure 1—figure supplement 3A
CpG TLR9 Nur77-eGFP B cells Zikherman et al. (2012), Figure S1G; Manuscript
Figure 1—figure supplement 3A
Pam3CSK4 TLR1/2 Nur77-eGFP B cells Manuscript Figure 1—figure supplement 3A
Anti-Igk BCR Nur77-eGFP B cells Manuscript Figure 2F
Modulates pathway at steady state in
vivo
IgHEL Tg Antigen/
BCR
Nur77-eGFP B cells Zikherman et al. (2012), Figure 3B,C;
Manuscript Figure 1A
IgHEL BCR
Tg/sHEL Ag
Antigen/
BCR
Nur77-eGFP B cells Zikherman et al. (2012), Figure 3B,C; Manuscript
Figure 1A
Lyn-/- BCR via
ITIMs
Nur77-eGFP B cells Manuscript Figure 5—figure supplement 3A
CD45 allelic
series
BCR via
SFKs
Nur77-eGFP B cells Zikherman et al. (2012), Figure 3A,B
DOI: https://doi.org/10.7554/eLife.35074.010
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Figure 2. IgD signals strongly in vitro but weakly in vivo. (A) Median intracellular pErk in splenic CD23+ B cells
stimulated with anti-Igk for 15 min. (B) Erk phosphorylation kinetics in splenic CD23+ B cells stimulated with 15 mg/
mL anti-Igk. (C) Splenocytes from IgM /  and IgD /  mice were loaded with Indo-1 and stimulated with 2.5 or 5
mg/mL anti-Igk. B220+CD23+CD93- Fo B cells are compared. (D) CD86 induction in CD23+ IgM /  and IgD / 
splenocytes stimulated with anti-Igk for 18 hr. (E) Summary data for CD86 MFI in (D). (F) Nur77-eGFP induction in
cells from (D). (G) Nur77-eGFP in cells from (D) incubated with medium alone (0 mg/mL anti-Igk). (H)
Representative histograms and summary data for MHC-II induction in unstimulated cells from (D). (I) Basal calcium
in unstimulated IgM /  and IgD /  Fo B cells was calculated by normalizing the geometric mean of [Indo-1(violet)/
Indo-1(blue)] to WT B cells in the same experiment. For (A), signaling in cells from n = 2 IgM /  and IgD /  mice
is displayed, and results for 1.5, 3, and 15 mg/mL of anti-Igk were replicated in n = 3 independent experiments.
Data in (B) was compiled from n = 3 independent experiments with n = 3 mice of each genotype in each
experiment. Data in (C) are representative of n = 4 independent experiments for 5 mg/mL and n = 2 independent
experiments for 2.5 mg/mL. For (D-H), values were calculated for splenocytes from n = 3 mice of each genotype.
For (I), basal calcium ratios from n = 6 independent experiments are compiled. Welch’s t test was used to
calculate p values, and mean ±SEM is displayed. *p<0.05, **p<0.01, ***p<0.001.
DOI: https://doi.org/10.7554/eLife.35074.011
The following source data and figure supplement are available for figure 2:
Source data 1. Numerical data corresponding to Figure 2A and B, E-I, and Figure 2—figure supplement 1A.
DOI: https://doi.org/10.7554/eLife.35074.013
Source data 2. Numerical data corresponding to basal calcium in Figure 2I.
DOI: https://doi.org/10.7554/eLife.35074.014
Figure supplement 1. S6 and calcium signaling in IgM-/- and IgD-/- B cells.
DOI: https://doi.org/10.7554/eLife.35074.012
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Dual expression of IgM and IgD BCRs is required to establish a broad
dynamic range of BCR responsiveness across the repertoire
Surface IgM, but not IgD, expression is inversely correlated with endogenous antigen recognition
and GFP expression across a diverse repertoire of mature naı¨ve follicular (Fo) B cells, such that B
cells reactive to endogenous antigens express high levels of IgD and low levels of IgM on their sur-
face (Figure 1B) (Zikherman et al., 2012). The variation in surface IgM expression across the B cell
repertoire is profound, spanning a 100-fold range. However, because IgD is expressed at high and
invariant levels in all WT naı¨ve Fo B cells, total surface BCR, unlike IgM, has little dynamic range
across the WT repertoire (Figure 1—figure supplement 2A).
To explore how IgM and IgD differentially regulate B cells reactive to endogenous antigens, we
generated Nur77-eGFP mice deficient for either IgM or IgD (Lutz et al., 1998; Nitschke et al.,
1993). In IgM /  mice, all B cells express IgD alone prior to class switch recombination (CSR), and in
IgD /  mice, all B cells express IgM alone prior to CSR. We observed that IgM is still downregulated
Figure 3. Reduced in vivo antigen sensing by IgD in innate-like B cells. (A) Nur77-eGFP in peritoneal B1a (CD19
+CD5+CD23-) and splenic MZ (B220+CD21hiCD23lo) B cells from WT and IgM /  mice. (B) Nur77-eGFP in PtC-
binding peritoneal B1a cells from WT, IgM / , and IgD /  mice. (C) Nur77-eGFP and PtC MFIs were calculated for
total B1a and PtC-binding B1a cells. The ratio of the IgM /  (IgD-only) MFI to the IgD /  (IgM-only) MFI is
displayed with a 95% confidence interval. (D) Representative histograms of Nur77-eGFP in IgM /  and IgD / 
splenic MZ B cells from mice without (left) and with (right) a BAFF overexpression transgene. (E) Quantification of
Nur77-eGFP in MZ B cells from (D). For (A) and (E), n = 3 mice of each genotype were analyzed. For (B),
histograms are representative of n = 4 mice of each genotype. For (C), ratios are pooled for n = 4 mice of each
genotype from three independent experiments. For (D), histograms are representative of n = 3 mice of each
genotype. Welch’s t test (A and E) was used to calculate p values, and mean +SEM is displayed (except in C).
*p<0.05.
DOI: https://doi.org/10.7554/eLife.35074.015
The following source data and figure supplement are available for figure 3:
Source data 1. Numerical data corresponding to Nur77-eGFP and BCR expression in innate-like B cells in
Figures 3A, C, E, Figure 3—figure supplement 1A-C.
DOI: https://doi.org/10.7554/eLife.35074.017
Source data 2. Numerical data corresponding to Nur77-eGFP expression and PtC binding in B1a cells in Figure 3C.
DOI: https://doi.org/10.7554/eLife.35074.018
Figure supplement 1. The effect of BAFF, competition, and allotype on Igk and Nur77-eGFP expression.
DOI: https://doi.org/10.7554/eLife.35074.016
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on IgD /  GFPhi Fo B cells, but the dynamic range of IgM expression is highly restricted relative to
the broad range observed on WT cells (Figure 1B).
We previously showed that IgM down-modulation on GFPhi reporter B cells largely accounts for
impaired signaling through IgM (Figure 1C) (Zikherman et al., 2012). However, the narrow dynamic
range of IgM on IgD-deficient cells renders reporter B cells unable to fine-tune signaling through the
IgM BCR across the GFP repertoire (Figure 1C). Furthermore, IgD-mediated signaling is not altered
across the GFP repertoire in the presence or absence of IgM (Figure 1C). As a result, reduced
responsiveness of GFPhi B cells is most profound in B cells that express the IgM isotype in the pres-
ence of IgD. This suggests that IgD expression may be necessary to establish and/or maintain a
broad and functionally dynamic range of surface IgM expression across the B cell repertoire. This is
consistent with a previously proposed survival function for the IgD BCR (Roes and Rajewsky, 1993;
Sabouri et al., 2016).
IgM /  follicular B cells express more surface BCR than IgD /  follicular
B cells, but similar Nur77-eGFP
Deletion of either the IgM or the IgD BCR isotype results in compensatory upregulation of the
remaining isotype. This may be due in part to a change in competition for pairing with Iga/b hetero-
dimers, which is essential for trafficking of IgM to the cell surface (Hombach et al., 1990;
Sabouri et al., 2016). IgM /  B cells express about twice as much surface BCR as IgD /  B cells, as
measured by surface anti-light chain staining (Figure 1D and Figure 1—figure supplement 2B–E).
Nevertheless, distribution of Nur77-eGFP expression across the naı¨ve B cell repertoire is nearly iden-
tical in IgM /  and IgD /  Fo B cells (Figure 1E). Further, at every level of Nur77-eGFP, cells that
express IgD alone require more surface BCR to drive an equivalent amount of GFP compared to
cells that express IgM alone (Figure 1F). This suggests that on a per-receptor basis, IgD BCR may
be less efficient at inducing Nur77-eGFP in response to endogenous antigens. Importantly, this is
not attributable to differential dependence upon IgM or IgD expression for signaling via CXCR4 or
downstream of canonical TLR ligands (Figure 1—figure supplement 1C, Figure 1—figure supple-
ment 3A).
IgD BCR crosslinking induces robust signaling in vitro
Because IgD drives less Nur77-eGFP per receptor than IgM in vivo, we wanted to determine whether
there were defects in signal transduction downstream of IgD. To mimic antigen binding to the mem-
brane-distal end of the BCR and allow for direct comparison between the isotypes, we stimulated
IgD-only (IgM / ) and IgM-only (IgD / ) cells with anti-Igk and compared downstream signaling.
BCR ligation in IgD-only B cells induced equivalent amounts of Erk phosphorylation relative to IgM-
only B cells (Figure 2A), and there were no gross differences in pErk kinetics (Figure 2B). Addition-
ally, IgD-only cells induced more robust intracellular calcium increase and S6 phosphorylation than
IgM-only cells (Figure 2C and Figure 2—figure supplement 1A). This was not due to differential
effects of the Fc portion of the stimulatory antibody on IgM-only and IgD-only B cells as anti-Igk-F
(ab’)2 and anti-Igk stimulation produced identical signaling (Figure 2—figure supplement 1B).
IgD BCRs sense endogenous antigens less efficiently than IgM BCRs
Due in part to increased surface receptor expression, IgD-only B cells induce comparable Erk phos-
phorylation and enhanced calcium mobilization relative to IgM-only B cells stimulated with anti-Igk.
As a result, we observe significantly more CD86 and Nur77-eGFP induction in IgD-only B cells after
18 hr of anti-Igk stimulation in vitro (Figure 2D–F). However, IgD-only cells induced less Nur77-
eGFP and MHC-II upregulation when cultured in the absence of exogenous stimulus (Figure 2G and
H). This discrepancy suggests that despite increased receptor expression and efficient coupling to
downstream signaling machinery, residual endogenous antigens occupying the IgD BCR are less effi-
cient at inducing signaling ex vivo. Consistent with this hypothesis, basal calcium analyzed immedi-
ately ex vivo is depressed in cells that express only IgD (Figure 2I). These data suggest that while
signal transduction downstream of the IgD BCR is robust in vitro, IgD responds less efficiently than
IgM to the relevant antigens it encounters in vivo.
Noviski et al. eLife 2018;7:e35074. DOI: https://doi.org/10.7554/eLife.35074 8 of 29
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Reduced endogenous antigen sensing by IgD BCR in innate-like B cells
While IgD-only and IgM-only Fo B cells express comparable levels of Nur77-eGFP (Figure 1E), we
suspected that competitive pressures for survival might constrain the acceptable range of BCR sig-
naling among mature Fo B cells. We further speculated that compensatory mechanisms such as
altered surface receptor and altered BCR repertoire might fine tune how much signaling Fo B cells
experience in vivo in order to lie within this range. In contrast to Fo B cells, IgD-only marginal zone
(MZ) and B1a cells expressed significantly less Nur77-eGFP than WT cells despite higher levels of
surface BCR (Figure 3A, Figure 1—figure supplement 2B–E). To determine whether this difference
was due to isotype or altered BCR repertoire, we probed GFP expression in B1a cells specific for
phosphatidylcholine (PtC), an endogenous antigen exposed on the surface of dying cells that is
thought to select developing B cells into the B1a compartment (Baumgarth, 2011). We found a
large difference in GFP even among B1a cells with a common specificity, and this occurs in spite of
high surface PtC binding in IgD-only B1a cells (Figure 3B and C).
We took an independent and complementary approach to address the same question in MZ B
cells; we crossed IgM /  and IgD /  reporter mice to a genetic background that drives over-expres-
sion of the B cell survival factor BAFF (Gavin et al., 2005). BAFF overexpression ‘unrestricts’ the
BCR repertoire by removing competition for survival, thereby reducing both positive and negative
selection pressures and permitting cells with either insufficient or excessive BCR signaling to persist
in the repertoire, resulting in a massively expanded MZ compartment (Stadanlick and Cancro,
2008). Importantly, BAFF does not directly regulate reporter GFP expression, and therefore GFP
reflects endogenous antigen stimulation on this genetic background (Zikherman et al., 2012). In
BAFF Tg mice, IgD-only MZ cells expressed much less GFP than those expressing IgM alone
(Figure 3D and E). This was not explained by differences in surface receptor levels between these
populations as they are comparable on this genetic background (Figure 3—figure supplement 1A).
Indeed, IgD-only cells with low GFP and IgM-only cells with high GFP appear to be preferentially res-
cued in mice with excess BAFF, suggesting that distinct BCR repertoires, far from accounting for
GFP differences between IgM-only and IgD-only MZ B cells, actually obscure these differences. Con-
versely, either ‘fixing’ or unrestricting the BCR repertoire unmasks impaired GFP upregulation by
IgD relative to IgM.
As a result of allelic exclusion of the heavy chain locus during B cell development, IgM+/  hetero-
zygous mice develop two genetically distinct sets of B cells in which half express only IgD and the
other half express both IgM and IgD. We exploited this property to confirm that the Nur77-eGFP
difference in the MZ and B1a compartments is cell intrinsic and not a consequence of the presence
or absence of serum IgM (Figure 3—figure supplement 1B).
Since IgM /  and IgD /  mice were generated on the Balb/c and 129 genetic backgrounds
respectively, their germline VDJ loci are different from that of C57BL/6 mice to which they have
been back-crossed. Throughout our study, we have validated our findings in either Balb/c-B6 F1
mice or IgHa/b heterozygous mice, which have two sets B cells with identical IgM and IgD isotype
expression but distinct germline VDJ loci. We took this approach to confirm that differences in MZ
GFP were due to BCR isotype and not VDJ locus (Figure 3—figure supplement 1C).
Cell-intrinsic skewing of B cell development by the IgM and IgD BCRs
Generation of the B1a compartment requires endogenous antigen recognition and strong BCR sig-
naling, while the opposite is true for MZ B cells (Figure 4—figure supplement 1A) (Cariappa and
Pillai, 2002; Casola et al., 2004). Indeed, B1a cells are modestly reduced in IgM-deficient mice,
while MZ B cells are modestly increased (Figure 4—figure supplement 1B–C). Because serum IgM
deficiency leads to increased B1a numbers, we assessed B1a and MZ B cell development in a com-
petitive setting to isolate the cell-intrinsic effects of IgM and IgD BCRs (Boes et al., 1998). Analo-
gous to the IgM+/  mice described above, IgM+/  IgD /+ heterozygous mice develop two
genetically distinct sets of B cells in which half express only IgD and the other half express only IgM
(Figure 4A). Although IgD-only B cells can partially populate the B1a compartment in the absence
of competition (Lutz et al., 1998; U¨belhart et al., 2015), IgD-only cells are virtually excluded from
this compartment in a competitive setting (Figure 4B). Indeed, this parallels the loss of PtC-binding
IgD-only peritoneal B cells observed in competition with wild type cells (U¨belhart et al., 2015). In
contrast, IgD-only B cells preferentially populate the MZ B cell compartment in competition with
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IgM-only B cells (Figure 4B). These data are consistent with a signal strength model of B1a/MZ B
cell development (Figure 4—figure supplement 1A), and this suggests that in vivo signaling, anti-
gen recognition, or both are reduced in IgD-only B cells. These differences in signaling could in turn
modulate the generation and/or survival of IgD-only B1a and MZ B cells.
We sought to determine whether skewed development of B cell lineages was driven primarily by
properties of IgD, IgM, or both by comparing development of B cell populations in IgM+/  IgD /+,
Figure 4. Cell-intrinsic skewing of B cell development by IgM and IgD BCRs. (A) Allelic exclusion leads to a 1:1
mixture of IgM-only and IgD-only B cells in IgM+/  IgD /+ mice. (B) Proportion of peritoneal B1a (CD19+CD5
+CD23-) and splenic MZ (B220+CD21hiCD23lo) B cells originating from each Ig locus in IgM+/  IgD /+ mice. (C)
Relative competition between IgM+ and IgD+ B cells in IgM+/  IgD /+ mice was calculated for bone marrow,
splenic, and peritoneal B cell compartments. Results include data from (B) for reference. Immature (CD23-CD93+);
T2-like (CD23+CD93+); mature recirculating (CD23+CD93-); T1 (CD93+CD23-); T2/3 (CD93+CD23+); Fo (CD93-
CD23+); MZ (CD21hiCD23lo); B1a (CD5+CD23-); B1b (CD5-CD23-); B2 (CD5-CD23+). (D) Relative competition
between WT (IgMb+) and IgM-null (IgDa+) B cells in IgM+/  mice was determined as in (C). (E) Relative
competition between WT (IgMb+) and IgD-null (IgMa+) B cells in IgD+/  mice was determined for splenic and
peritoneal compartments as described in (C). (F) Competition in peritoneal B1a and splenic MZ compartments in
IgM+/  mice with or without a BAFF overexpression transgene. Results include data from (D) for reference. For (B)
and (C), n = 3–5 mice were analyzed. For (D), n = 3–8 mice were analyzed. For (E), n = 5 mice were analyzed. For
(F), n = 4–5 mice of each genotype were analyzed. Welch’s t test was used to calculate p values, and mean ±SEM
is displayed. **p<0.01, ***p<0.001.
DOI: https://doi.org/10.7554/eLife.35074.019
The following source data and figure supplement are available for figure 4:
Source data 1. Numerical data corresponding to competition between IgM-only, IgD-only and WT B cells in
Figure 4B–F, and in Figure 4—figure supplement 1B-D
DOI: https://doi.org/10.7554/eLife.35074.021
Source data 2. Numerical data corresponding to competition between IgM-only, IgD-only and WT B cells in
Figure 4B–E.
DOI: https://doi.org/10.7554/eLife.35074.022
Source data 3. Numerical data corresponding to competition between IgD-only and WT B cells in Figure 4F.
DOI: https://doi.org/10.7554/eLife.35074.023
Figure supplement 1. B cell subset development in IgM / , IgD / , WT, and IgHa/b mice.
DOI: https://doi.org/10.7554/eLife.35074.020
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IgM+/ , and IgD+/  mice (Figure 4C–4E). We conclude that skewing of MZ and B1a fates is primarily
attributable to lack of IgM expression on IgD-only cells rather than lack of IgD expression on IgM-
only cells because we observe little skewing in IgD+/  mice (Figure 4E). Further, the competitive
advantage of IgD-only cells in the marginal zone niche is reduced by BAFF over-expression, consis-
tent with loosening of competitive selection pressures (Figure 4F).
IgM-only B cells exhibit a disadvantage in the mature Fo compartment relative to IgD-only B cells
(Figure 4C). We find that absence of IgD rather than excess IgM expression accounts for some of
this disadvantage as WT and IgD-only cells compete equally well in this compartment (Figure 4D).
This may reflect impaired positive selection or survival in absence of IgD. Indeed, similar to our
observations, a disadvantage for Fo B cells lacking IgD was observed in IgD+/  mice previously
(Roes and Rajewsky, 1993). As with differences in Nur77-eGFP expression, we confirmed that the
developmental fates of IgM-only and IgD-only cells were due to BCR isotype and not VDJ locus (Fig-
ure 4—figure supplement 1D).
Either IgD or IgM BCR is sufficient to mediate polyclonal B cell
activation and germinal center differentiation in Lyn /  mice
Mice deficient for either IgM or IgD can mount T-independent and T-dependent immune responses
to model antigens (Lutz et al., 1998; Nitschke et al., 1993; Roes and Rajewsky, 1993). However,
endogenous antigens may have unique properties that are absent in model antigen systems. To test
whether each BCR isotype was competent to mediate autoimmune responses to endogenous anti-
gens in lupus-prone mice, we generated IgM+/  and IgD+/  mice on the Lyn /  background
(Chan et al., 1997). The Src family kinase Lyn is essential to mediate ITIM-dependent inhibitory sig-
nals in B cells and myeloid cells (Scapini et al., 2009; Xu et al., 2005). Lyn /  mice consequently
develop a spontaneous lupus-like disease characterized by anti-DNA antibodies and nephritis on the
C57BL/6 genetic background (Chan et al., 1997; Hibbs et al., 1995; Nishizumi et al., 1995). It has
been shown that both B-cell-specific MyD88 expression and T cells are essential for IgG2a/c anti-
dsDNA autoantibody production in Lyn /  mice, and conditional deletion of Lyn in B cells is suffi-
cient for autoimmunity (Hua et al., 2014; Lamagna et al., 2014).
Secreted natural IgM is thought to play important homeostatic functions that repress autoimmu-
nity, particularly clearance of dead cell debris (Boes et al., 2000; Manson et al., 2005). By perform-
ing our analysis in mice with wild type and IgM-only or IgD-only B cells in a common milieu (IgM+/ 
Lyn /  and IgD+/  Lyn /  mice), we could control for this and isolate the B cell-intrinsic effects of
the IgM and IgD BCRs. Importantly, precursor Fo B cells are present at roughly equal ratios from WT
and IgM-only or IgD-only loci in these mice, and this is unaffected by VDJ background (Figure 5—
figure supplement 1A–C). Moreover, Lyn /  B cells expressing either IgM or IgD alone exhibit
enhanced BCR signaling in vitro relative to Lyn+/+ B cells, suggesting that neither isotype is uniquely
coupled to ITIM-containing receptors (Figure 5—figure supplement 2A–B).
Polyclonal B cell activation in Lyn /  mice precedes and is genetically separable from autoanti-
body production; it is driven by B cell-intrinsic loss of Lyn, is thought to result from enhanced BCR
signaling, and is independent of MyD88 expression (Hua et al., 2014; Lamagna et al., 2014).
Indeed, Lyn /  reporter B cells have elevated Nur77-eGFP expression consistent with enhanced BCR
signal transduction in vivo (Figure 5—figure supplement 3A). We had expected that activation of
IgD-only Lyn /  B cells might be impaired due to reduced sensing of endogenous antigens, but nei-
ther CD86 nor CD69 upregulation were significantly different on WT and IgD-only B cells in the
absence of Lyn (Figure 5A). This implies that both BCRs can provide sufficient signals to drive poly-
clonal activation by endogenous antigens.
Although GC fate is disfavored relative to SLPC fate in Lyn /  mice, GCs do arise spontaneously
with time (Hibbs et al., 1995; Hua et al., 2014). We found that both IgD-only and IgM-only cells in
Lyn-deficient mice made comparable contributions to the GC compartment in competition with wild
type B cells, independent of VDJ background (Figure 5B and Figure 5—figure supplement 3B–C).
We propose that endogenous antigen sensing by IgD, while normally dampened, is sufficient to
drive both polyclonal activation and GC differentiation on the Lyn /  background. This further
implies that antigen capture by IgD and presentation on MHC-II is robust enough to recruit ade-
quate T cell help to support these cell fates.
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Figure 5. IgD can drive polyclonal activation and germinal center entry, but not anti-dsDNA IgG2a production, in
Lyn /  mice. (A) Surface CD69 and CD86 expression on CD23+ splenic B cells from each Ig locus in IgM+/  mice
on Lyn+/+ and Lyn /  backgrounds. (B) Percentage of unswitched germinal center (CD19+ Fashi GL-7hi IgM/IgD+)
B cells from each Ig locus in IgM+/  and IgD+/  mice on the Lyn /  background. (C) Anti-dsDNA IgG2a titers from
each Ig locus in IgM+/  Lyn /  mice were calculated by ELISA using pooled IgHa/b autoimmune serum with high-
titer autoantibodies from each locus as a reference (titer set at 1000). Each color represents a single mouse
tracked over time. (D) Anti-dsDNA IgG2a titers in IgD+/  Lyn /  mice were calculated as in (C). (E) Paired anti-
dsDNA titers from each locus in individual IgM+/  Lyn /  mice from (C) with additional mice from 24 weeks to 12
months. (F) Paired anti-dsDNA titers from each locus in IgD+/  Lyn /  mice from (D). (G) Ratio of anti-dsDNA
IgG2a[a] to IgG2a[b] from all samples in (E) and (F) with an anti-dsDNA IgG2a titer >250 from either locus; cutoff
defined by titers in young WT mice. For (A), n = 4 IgM+/  Lyn /  mice are compared to a reference IgM+/  Lyn+/+
mouse. Qualitatively similar results were obtained in two independent experiments. For (B) n = 5–6 mice of each
genotype were analyzed. For (C) and (D), n = 9 and n = 12 mice were tracked. For (G), n = 36 IgM+/  Lyn /  and n
= 39 IgD+/  Lyn /  anti-dsDNA IgG2a+ samples were compared. Welch’s t test was used to calculate p values,
and mean ±SEM is displayed. **p<0.01.
DOI: https://doi.org/10.7554/eLife.35074.024
The following source data and figure supplements are available for figure 5:
Source data 1. Numerical data corresponding to Figure 5A-G,Figure 5—figure supplement 1B-C, 3C-E.
DOI: https://doi.org/10.7554/eLife.35074.028
Figure supplement 1. Splenic B cell subsets in IgHa/b, IgM+/ , and IgD+/  Lyn /  mice.
DOI: https://doi.org/10.7554/eLife.35074.025
Figure supplement 2. Signaling in IgM+/  and IgD+/  Lyn /  B cells.
DOI: https://doi.org/10.7554/eLife.35074.026
Figure supplement 3. Nur77-eGFP in Lyn /  B cells and the role of BCR allotype in Lyn /  phenotypes.
DOI: https://doi.org/10.7554/eLife.35074.027
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IgM BCR is required to drive dsDNA antibody production in Lyn / 
mice
IgM- and IgD-deficient B cells express BCR heavy chain allotype [a] (IgHa), and their secreted anti-
bodies can be differentiated from WT B6 antibodies (IgHb) even after isotype switching (e.g. IgG2a
[a] vs. IgG2a[b] – also referred to as IgG2c). Allotype-specific antibodies have been previously used
in the context of lupus mouse models to track autoantibodies generated by B cells of distinct
genetic origin (Mills et al., 2015; Pisitkun et al., 2006). We took an analogous approach to assess
IgG2a/c anti-dsDNA autoantibodies emanating from each genetic locus in IgM+/ , IgD+/ , and IgHa/
b control mice deficient for Lyn. In order to compensate for reduced penetrance of autoantibody
production in IgM+/  Lyn /  mice, we collected serum from this genotype at time points beyond 24
weeks to increase the number of samples in which tolerance had been broken. While B cells express-
ing IgM (of either IgH locus) generated IgG2a/c anti-dsDNA, IgD-only B cells were relatively pro-
tected from generating anti-dsDNA antibodies, even at late time points (Figure 5C–G, Figure 5—
figure supplement 3D–E). Importantly, this is attributable to BCR isotype and not VDJ locus (Fig-
ure 5—figure supplement 3D–E).
We noted that anti-dsDNA antibody titers fluctuated substantially over time in Lyn /  mice, in
some cases dropping markedly over a four-week period (Figure 5C and D). Anti-dsDNA IgG autoan-
tibodies in patients with systemic lupus erythematosus (SLE) similarly fluctuate over time – in contrast
to other anti-nuclear specificities - and correlate with disease flares (Liu et al., 2011). Furthermore,
unmutated germline BCRs from naı¨ve B cells are recruited directly into the circulating plasmablast
compartment during SLE flares (Tipton et al., 2015). Taken together, this suggests that anti-dsDNA
antibodies in mice and humans are secreted at least in part by SLPCs emerging from an extra-follicu-
lar immune response, rather than long-lived plasma cells (LLPCs) that originate in GCs. Our data sug-
gests that, in the absence of Lyn, the IgD BCR is sufficient to mediate B cell activation and GC entry,
but the IgM BCR is essential to produce dsDNA-specific SLPCs.
IgM BCR is required for expansion of unswitched plasma cells in Lyn / 
mice
In addition to stochastic generation of autoantibodies over time, Lyn /  mice exhibit a massive
expansion of the splenic IgM plasma cell compartment that corresponds to a roughly 10-fold
increase in serum IgM (Hibbs et al., 1995). While natural IgM is thought to be secreted by B1a-
derived plasma cells (Baumgarth, 2011), elevated serum IgM in Lyn /  mice arises from the Fo B2
compartment since Lyn /  mice lack MZ B cells, and bone marrow chimeras lacking the B1a com-
partment reconstitute the hyper-IgM secretion phenotype (Luo et al., 2014). Moreover, while BCR
signaling is prominently enhanced in Lyn /  B2 B cells, it is markedly dampened in Lyn /  B1a cells
(Figure 6—figure supplement 1A) (Skrzypczynska et al., 2016).
IgM plasma cell expansion is temporally and genetically separable from autoimmunity in Lyn / 
mice; this phenotype develops in mice as young as 7–10 weeks of age with 100% penetrance, is
B-cell intrinsic, and is not dependent upon MyD88 expression (Hua et al., 2014; Infantino et al.,
2014; Lamagna et al., 2014). A pathway involving Btk, Ets1, and Blimp-1 is thought to drive this
phenotype. Ets1 inhibits plasma cell differentiation in part by antagonizing the key transcriptional
regulator of plasma cell fate, Blimp-1 (John et al., 2008). Mice deficient for Ets1 display IgM plasma
cell expansion, Ets1 levels are reduced in Lyn /  mice, and restoration of Ets1 expression normalizes
IgM plasma cell numbers (Luo et al., 2014). Furthermore, reducing levels of Btk, a critical kinase
that mediates BCR signaling, is sufficient to suppress IgM plasma cell expansion in Lyn /  mice, and
Ets1 levels are concomitantly restored to normal levels in Btklo Lyn /  mice (Gutierrez et al., 2010;
Luo et al., 2014; Mayeux et al., 2015). Therefore, IgM plasma cell expansion in Lyn-/- mice is driven
by exaggerated Btk-dependent BCR stimulation of B2 B cells by endogenous antigens (Figure 6—
figure supplement 2A). Indeed, enhanced BCR signaling has been shown to favor SLPC fate over
GC differentiation in Lyn-sufficient mice as well (Chan et al., 2009; Nutt et al., 2015; Paus et al.,
2006). We therefore wondered whether impaired endogenous antigen sensing by IgD influenced
Ets1 expression and unswitched PC expansion in Lyn /  mice.
As previously shown, Lyn /  B cells downregulate Ets1 protein expression (Figure 6A) (Luo et al.,
2014). However, Lyn-deficient B cells expressing only IgD did not do so, consistent with a reduced
ability of IgD to transmit antigen-dependent signals in vivo (Figure 6A). As previously reported, we
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found that the frequency of plasma cells in the spleens of Lyn /  mice was increased fourfold relative
to Lyn+/+ mice, but the bone marrow plasma cell compartment size was relatively unaffected
(Figure 6B–C) (Infantino et al., 2014). The increase in splenic plasma cells was attributable entirely
to unswitched (IgM+) plasma cells (Figure 6C). However, unswitched plasma cell expansion was
completely absent in IgM /  Lyn /  spleens (Figure 6C). This was reflected in steady-state serum
antibody levels; while Lyn /  mice have elevated serum IgM relative to WT mice, IgM /  Lyn / 
mice did not have elevated serum IgD relative to IgM /  mice (Figure 6D–E).
To confirm that resistance to unswitched plasma cell expansion was a cell-intrinsic feature of IgD-
only Lyn /  B cells, we assessed this phenotype in IgM+/  Lyn /  mice. Similar to the non-competi-
tive setting, IgD-only Lyn /  cells did not contribute to an expansion in the unswitched plasma cell
compartment (Figure 6F-G). This effect was due to isotype and not VDJ allele usage because both
Figure 6. Cell-intrinsic IgM expression is required for unswitched plasma cell expansion in Lyn /  mice. (A) Representative blot and quantification of
Ets1 and GAPDH protein in purified splenic B cells from WT, Lyn / , and IgM /  Lyn /  mice. (B) Composition of the CD138+ plasma cell
compartments in the spleen and bone marrow of WT, Lyn / , and IgM /  Lyn /  mice was determined by intracellular staining of IgM, IgD, and IgA.
(C) Percentages in (B) multiplied by the fraction of live cells positive for CD138 in each tissue. Unswitched cells are positive for either IgM or IgD.
Statistics correspond to unswitched plasma cell percentages; differences in IgA+ cells were not significant. (D) Serum IgM in 16-week-old mice was
quantified for B6.IgHa (WT) and Lyn /  mice by ELISA. A sample from an IgM /  mouse is shown for reference. (E) Serum IgD in 16-week-old mice was
quantified for IgM /  and IgM /  Lyn /  mice by ELISA. A sample from a WT mouse is shown for reference. (F) Gating scheme for quantifying the
unswitched splenic plasma cell composition of IgM+/  Lyn /  mice. (G) Percentage of unswitched splenic plasma cells (CD138+B220loIgM/IgD+) from
each locus in IgM+/  and IgD+/  mice on the Lyn /  background. For (B) and (C), figures are representative of n = 4–5 mice of each genotype. For (D),
values from n = 3 WT and n = 4 Lyn /  mice are averaged. For (E), values from n = 3 IgM /  and n = 4 IgM /  Lyn /  mice are averaged. For (F) and
(G), n = 4–5 mice of each genotype were used. Welch’s t test was used to calculate p values, and mean ±SEM is displayed. *p<0.05, **p<0.01,
***p<0.001.
DOI: https://doi.org/10.7554/eLife.35074.029
The following source data and figure supplements are available for figure 6:
Source data 1. Numerical data corresponding to Ets1 expression, plasma cell compartments, and serum IgM and IgD titers in Figure 6A-G.
DOI: https://doi.org/10.7554/eLife.35074.032
Source data 2. Numerical data corresponding to Ets1 expression in splenic B cells in Figure 6A.
DOI: https://doi.org/10.7554/eLife.35074.033
Source data 3. Numerical data corresponding to plasma cell compartments in Figure 6B–C.
DOI: https://doi.org/10.7554/eLife.35074.034
Figure supplement 1. BCR signaling in Lyn /  peritoneal B cell subsets.
DOI: https://doi.org/10.7554/eLife.35074.030
Figure supplement 2. Lyn restrains unswitched plasma cell differentiation of follicular B cells.
DOI: https://doi.org/10.7554/eLife.35074.031
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IgHa and IgHb B cells in IgHa/b Lyn-/- mice generated unswitched plasma cells in a competitive setting
(Figure 5—figure supplement 3C).
IgM BCR is required for efficient generation of short-lived IgG1+
plasma cells but is dispensable for GC B cell fate
IgD-only Lyn /  Fo B cells are completely prevented from generating an expanded unswitched SLPC
compartment in response to chronic endogenous antigen stimulation, but they are competent to
enter the GC. To determine how this defect relates to responses towards exogenous model anti-
gens, we sought to determine whether IgD-only Lyn+/+ B cells exhibit skewing of cell fate in the con-
text of a T-dependent response to a model antigen. To generate a robust polyclonal B cell response
in which T cell help should not be limiting, we used the classic immunogen sheep RBCs. During this
immune response, Fo B cells can either enter the germinal center or rapidly differentiate into IgG1+-
SLPCs (Chan et al., 2009; Paus et al., 2006). We found that wild type, IgM / , and IgD /  mice all
produced extremely robust GC responses 5 days after SRBC injection, but B cells expressing IgD
alone were unable to produce IgG1+ SLPCs at this time point (Figure 7A–D).
Since serum IgM is absent in IgM /  mice and is known to enhance PC generation (Boes et al.,
1998), we wanted to assess the cell-intrinsic effect of IgD and IgM BCRs on the immune response to
SRBCs. To do so, we immunized IgM+/  mice in which half of Fo B cells express IgD alone and half
express both IgM and IgD. We could track the relative contribution of these two cell populations to
the GC response because the bulk of GC B cells have not yet isotype-switched and express surface
IgM or IgD. Both cell types made a robust contribution to the germinal center response (Figure 7E).
Next we tracked the generation of IgG1+ PCs by detecting allotype [a] or allotype [b] IgG1. In con-
trast to the GC response, IgD-only B cells were significantly disfavored in this compartment,
although the defect was less severe than that observed in IgM /  mice, which lack serum IgM
(Figure 7F). To control for differences in the VDJ locus, we performed this experiment using IgHa/b
control mice and observed no significant differences between allotypes, implying that BCR isotypes
rather than VDJ locus accounted for our observations (Figure 7—figure supplement 1A–B).
In contrast to impaired IgG1 SLPC responses by IgD-only B cells, we observed that IgD-only B
cells were able to generate unswitched plasma cells in response to SRBC immunization in both non-
competitive and competitive settings (Figure 7—figure supplement 1C–D). Unswitched PC num-
bers correlate well with MZ B cell numbers in these mice (Figure 4—figure supplements 1B and
Figure 4D). Moreover, MZ B cells efficiently generate short-lived unswitched plasma cells even in
response to TD-antigens (Phan et al., 2005; Song and Cerny, 2003). We therefore suspect that
IgG1 PCs emanate from the Fo B cell compartment, while the unswitched PC response may origi-
nate in the MZ B cell compartment. Normal SLPC generation by IgM-deficient MZ B cells in response
to immunization would be consistent with previously reported normal T-independent II responses in
IgM-deficient mice (Lutz et al., 1998). However, we cannot exclude a contribution of follicular-
derived PCs that have failed to class switch to IgG1.
We sought to confirm that the IgG1+ PC defect was generalizable to other T-dependent immuno-
gens. The B cell response to NP hapten is stereotyped and makes predominant use of the VH186.2
heavy chain (Loh et al., 1983). We therefore immunized both IgM+/  and IgHa/b mice with NP hap-
ten conjugated to rabbit serum albumin (NP-RSA) in order to control for differences in VDJ locus.
Although allotype [a] makes a less robust response to NP than allotype [b], we normalized responses
of IgD-only cells to wild type allotype [a] cells and found that GC responses at early time points were
intact, but IgG1+ PCs and NP-specific IgG1 titers were significantly reduced 7–8 days after immuni-
zation (Figure 7G–I). These data suggest that IgD-only follicular B cells are competent to enter the
GC, but they have defects in adopting the SLPC fate (or class-switching) in response to T-dependent
immunization.
Discussion
We and others previously hypothesized that a major tolerance strategy employed by autoreactive Fo
B cells is selective downregulation of IgM. However, since all Fo B cells express a high and invariant
amount of surface IgD, it was unclear whether and how loss of IgM expression could affect B cell
responses to antigenic stimulation. It was recently reported that IgM, but not IgD, is uniquely
responsive to monomeric antigens due to a short and inflexible linker region coupling the Fab and
Noviski et al. eLife 2018;7:e35074. DOI: https://doi.org/10.7554/eLife.35074 15 of 29
Research article Immunology and Inflammation
Fc portions of IgM (U¨belhart et al., 2015). This could account for selective quiescence of mildly
autoreactive B cells to monovalent endogenous antigens. However, the identity and structural char-
acteristics of endogenous antigens are not well understood, and include cell-surface antigens on the
surface of red cells and B cells (Qua´ch et al., 2011; Reed et al., 2016). Moreover, recent work from
Goodnow and colleagues showed that HEL-specific IgD BCR, when expressed on primary mouse
splenocytes, can indeed mobilize calcium in vitro and can mediate gene expression changes in vivo
in response to monovalent cognate antigen (Sabouri et al., 2016).
How do our observations help move beyond and reconcile the seemingly contradictory published
work on antigen sensing by IgM and IgD? In vitro signaling studies of HEL-specific BCRs by the
Jumaa and Goodnow labs differ in several important ways; the former work assesses calcium signal-
ing in pre-B cells that lack Slp-65 expression, while the latter studies splenic B cells with a consider-
ably more mature phenotype. In addition, differences in reagents or strength of stimulus may also
Figure 7. IgD-only cells have intact germinal center responses but impaired IgG1+ SLPC responses. (A) Splenic (CD19+) B cells from WT, IgM / , and
IgD /  mice unimmunized or 5 days after i.p. immunization with 200 mL of 10% SRBCs. (B) Quantification of germinal center (Fashi GL-7hi) cells in (A). (C)
Splenocytes from mice in (A). (D) Quantification of CD138+ IgG1+ plasma cells in (C). (E) WT (IgMb+) and IgM-null (IgDa+) germinal center B cells as a
percentage of live splenocytes in unimmunized and IgM+/  mice 5 days after i.p. immunization with 200 mL of 10% SRBCs. (F) WT (IgG1b+) and IgM-null
(IgG1a+) switched plasma cells (CD138 +IgG1+) as a percentage of live splenocytes in IgM+/  mice unimmunized or 5 days after i.p. immunization with
200 mL of 10% SRBCs. (G) Fraction of unswitched NP-specific germinal center cells (CD19+ Fashi GL-7hi IgM/IgD+) from the IgHa locus in the spleens of
Balb/c-B6 F1 and IgM+/  mice 7–8 days after i.p. immunization with 100 mg NP-RSA. (H) Fraction of IgG1+CD138+ plasma cells from the IgHa locus in
Balb/c-B6 F1 and IgM+/  mice 7–8 days after i.p. immunization with 100 mg NP-RSA. (I) NP-specific IgG1a and IgG1b titers at OD = 0.2 were calculated
for the mice in (G–H) by ELISA. The IgG1a to IgG1b titer ratio was calculated for each mouse, and all ratios were normalized such that the average
IgG1a/IgG1b ratio in Balb/c-B6 F1 samples = 1.0. For (A-D), statistics from n = 4 unimmunized mice of each genotype and n = 3 WT, n = 6 IgM / , and
n = 7 IgD /  immunized mice were pooled. For (E-F), n = 5 unimmunized and n = 5 immunized mice are shown. For (G-I), n = 5 Balb/c-B6 F1 mice and
n = 3 IgM+/  mice are shown. One-way ANOVA with Tukey’s multiple comparisons test (B and D), a paired t test (E-F), and Welch’s t test (G-I) were
used to calculate p values, and mean +SEM is displayed. *p<0.05, **p<0.01, ***p<0.001.
DOI: https://doi.org/10.7554/eLife.35074.035
The following source data and figure supplements are available for figure 7:
Source data 1. Numerical data corresponding to germinal center and plasma cell responses in Figure 7B-I,Figure 7—figure supplement 1A–D
DOI: https://doi.org/10.7554/eLife.35074.038
Figure supplement 1. Role of BCR allotype and generation of unswitched plasma cells in SRBC-immunized mice.
DOI: https://doi.org/10.7554/eLife.35074.036
Figure supplement 2. Role of IgM and IgD in regulating rapid antibody responses.
DOI: https://doi.org/10.7554/eLife.35074.037
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contribute to opposing conclusions. Our data suggests that the reduced sensitivity of IgD to bona
fide endogenous antigen may lie somewhere between these two extremes; we find that IgD can
sense endogenous antigens, just less efficiently than IgM. Consistent with this conclusion, both HEL-
specific IgM and IgD BCRs can mediate B cell anergy and drive a common gene expression program
in response to chronic high affinity soluble antigen exposure in vivo (Brink et al., 1992;
Sabouri et al., 2016).
Here we show that B cells expressing IgD BCR alone inefficiently sense endogenous antigens,
and exhibit impaired in vivo cell fate decisions that are dependent upon BCR signal strength. This is
epitomized by dramatic skewing of IgD-only B cells away from the B1a and towards the MZ fate in a
competitive setting. Importantly, signal transduction mediated by the IgD BCR in response to anti-
Igk stimulation in vitro is intact for all assayed parameters, suggesting that antigen sensing and sig-
nal initiation rather than signal transduction downstream of IgD is impaired. We propose that this
impaired sensing is conferred by structural properties of IgD, either through direct binding of anti-
gen and signal transduction through the BCR or through differential pairing with co-receptors that
directly modulate the BCR signaling pathway.
Characterization of bona fide endogenous antigens that drive Nur77-eGFP expression in the poly-
clonal repertoire is necessary in order to further dissect the biophysical basis for reduced antigen
sensing by IgD in vivo. These antigens may not be exclusively restricted to those that are germline-
encoded or generated by host enzymes; rather they may include non-inflammatory antigens taken
up through the gastrointestinal tract and recognized by specific BCRs. At least some relevant endog-
enous antigens may be membrane-bound (Qua´ch et al., 2011; Reed et al., 2016), and recent stud-
ies have illustrated the importance of membrane spreading, contraction, and stiffness discrimination
in BCR signaling (Fleire et al., 2006; Shaheen et al., 2017). We propose that relevant endogenous
antigens are presented in contexts that do not efficiently trigger signaling through the flexible struc-
ture of IgD. This might explain the discrepancy between weak responsiveness of IgD to endogenous
antigens in vivo and strong signaling in response to crosslinking antibodies in vitro.
An alternative mechanism is that differential clustering of co-receptors with IgD and IgM might
influence how BCR signals are integrated in vivo. It has long been proposed that there are not only
quantitative, but also qualitative differences between IgM and IgD signaling. Early studies of IgM
and IgD signaling in cell lines suggested that kinetics but not quality of signaling triggered by each
isotype differed (Kim and Reth, 1995). However, we have been unable to identify a difference in
kinetics of BCR signaling in primary IgM- or IgD-deficient B cells in vitro. More recently, studies using
TIRF, dSTORM, and PLA (proximity ligation assay) showed that IgD is more densely clustered on the
cell surface than IgM, and these distinct IgM- and IgD-containing ‘islands’ are differentially associ-
ated with co-receptors such as CD19 in resting and activated B cells (Kla¨sener et al., 2014;
Maity et al., 2015; Mattila et al., 2013). Since function of the ITIM-containing inhibitory co-receptor
CD22 depends on its ability to efficiently access the BCR, differences in cluster density of IgM and
IgD might render them differentially sensitive to such inhibitory tone (Gasparrini et al., 2016). It is
possible that differential association with such co-receptors contributes to differences in the function
of the IgM and IgD BCRs in vivo by modulating BCR signal strength, or by selectively perturbing
specific downstream signaling events.
In addition to B cell co-receptors that have long been known to directly modulate canonical BCR
signaling, a growing list of immunoreceptors expressed on B cells have more recently been shown
to require expression of the BCR for optimal function; Becker et al. have shown that expression of
the IgD BCR is critical for CXCR4-dependent signaling (Becker et al., 2017). This may influence the
biology of B cells expressing only IgM; indeed, CXCR4-deficient B cells exhibit reduced plasma cell
migration from spleen to bone marrow (but intact splenic SLPC responses) (Nie et al., 2004). Impor-
tantly, defective CXCR4 signaling in IgM-only B cells could not account for reduced Nur77-eGFP
expression in IgD-only B cells because reporter expression is insensitive to CXCR4 signaling (Fig-
ure 1—figure supplement 1C). Nor would it account for skewed cell fate decisions by IgD-only B
cells in competition with wild type B cells, both of which retain intact CXCR4 signaling. B cell
responses to TLR4 ligands also require expression of the BCR, but importantly, canonical TLR ligands
do not exhibit selective dependence on either the IgM or the IgD isotypes (Figure 1—figure supple-
ment 3A). Finally, recent work establishes a role for the Fc-receptor for IgM in modulating B cell
responses, and could therefore play a role downstream of serum IgM that is absent in IgM /  mice
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(Nguyen et al., 2017a; Nguyen et al., 2017b). We control for this effect by confirming that all phe-
notypes in this study are cell-intrinsic and independent of secreted IgM.
Accumulating evidence suggests that strong BCR signals favor SLPC over GC fate (Chan et al.,
2009; Nutt et al., 2015; Paus et al., 2006). This is thought to be transcriptionally mediated at least
in part by loss of Ets1 expression and induction of Irf4 in a BCR signal-strength dependent manner
(Nutt et al., 2015). Here we show that IgM and IgD are each sufficient to drive GC responses, but
IgD is less efficient at promoting SLPC fate in response to endogenous antigens, implying that IgDhi
IgMlo B cells may similarly be shunted away from SLPC responses. This discrepancy is unlikely to be
attributable to differences in antigen capture and presentation by the IgM and IgD BCRs, as GC
entry is highly T cell-help dependent. Instead, we provide evidence to suggest that reduced anti-
gen-dependent BCR signals are transduced in vivo by IgD. We show that, in the absence of Lyn,
Ets1 downregulation and unswitched PC expansion require the IgM BCR. IgM / Lyn /  mice pheno-
copy BtkloLyn /  mice; both strains are protected from Ets1-downregulation, PC expansion, and
anti-dsDNA autoantibody production in vivo (Mayeux et al., 2015; Whyburn et al., 2003). This sug-
gests that robust Btk-dependent Ets-1 downregulation in response to endogenous antigens relies
upon efficient antigen sensing by the IgM BCR and is important to drive unswitched PC expansion in
the absence of Lyn. It will be important to explore whether a similar mechanism accounts for
impaired IgG1+ SLPC responses by Lyn-sufficient B cells with low or absent IgM expression.
We propose that the purpose (and consequence) of IgM downregulation on autoreactive B cells
is to limit their direct differentiation into SLPCs in response to chronic endogenous antigen stimula-
tion, and prevent secretion of auto-antibodies in the context of an acute humoral immune response
(Figure 7—figure supplement 2A). However, IgD is sufficient to drive germinal center differentia-
tion without the contribution of IgM. This has been well-demonstrated both in the present study as
well as prior work (Lutz et al., 1998). Indeed, not only are autoreactive IgDhi IgMlo B cells competent
to enter the germinal center, they appear to do so with greater efficiency, perhaps due in part to
improved survival (Sabouri et al., 2016; Sabouri et al., 2014). It is worth emphasizing that selection
pressures and tolerance mechanisms operating within the germinal center must independently
ensure that somatic hypermutation both abolishes germ-line-encoded autoreactivity and prevents
de novo acquisition of autoreactivity. Goodnow and colleagues recently showed that autoreactive
BCRs can indeed be ‘redeemed’ by somatic hypermutation, providing proof-of-principle that entry
of autoreactive B cells into the GC does not necessarily pose a risk to the organism (Sabouri et al.,
2014).
Why, though, are autoreactive B cells preserved in the periphery and not deleted? Why is IgD
necessary at all? One suggestion is that such BCRs are retained in the pre-immune B cell compart-
ment to fill holes in the repertoire, and that IgD is essential for their survival; indeed, it has been
shown that loss of IgD expression, with or without compensatory upregulation of IgM, leads to loss
of mature naı¨ve B cells in competition (Roes and Rajewsky, 1993; Sabouri et al., 2016). We simi-
larly find that IgD-only B cells have a profound competitive advantage in the follicular B cell compart-
ment relative to IgM-only (but not WT) B cells, implying an obligate survival function for the IgD
isotype BCR. This is consistent with a well-appreciated pro-survival function of the BCR as demon-
strated by Rajewsky and colleagues (Kraus et al., 2004; Lam et al., 1997). Since IgD expression is
needed to keep IgMlo B cells alive, this may explain why IgD expression facilitates a broad dynamic
range of IgM expression across the B cell repertoire (Figure 1B,C), allowing B cells to fine-tune the
intensity of their SLPC responses according to their autoreactivity. IgD expression on IgMlo cells
could serve to mediate antigen capture and participation in T-dependent immune responses, while
simultaneously limiting SLPC responses as we show here.
We demonstrate here for the first time that IgD BCRs sense endogenous antigen more weakly
than IgM BCRs in vivo, are inefficient at driving SLPC responses to endogenous antigens, and
thereby may function to divert autoreactive follicular B cells from direct PC differentiation. We pro-
pose that this property of the IgD BCR limits generation of auto-reactive antibodies in the context of
immediate humoral immune responses. Taken together with recent work from the Jumaa and Good-
now groups, we propose a unified model of how IgM downregulation in the face of high IgD expres-
sion regulates the fate of naı¨ve autoreactive B cells in vivo while retaining their contribution to the
mature BCR repertoire.
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Materials and methods
Key resources table
Reagent type (species)
or resource Designation Source or reference Identifiers Additional information
Strain, strain background
(Mus musculus)
C56BL/6 The Jackson Laboratory;
Taconic
JAX:000664; TAC:BCNTac
Strain, strain background
(M. musculus)
Balb/C The Jackson Laboratory JAX:000651
Strain, strain background
(M. musculus)
Nur77-eGFP MMRRC UC Davis MMRRC:012015-UCD Characterized in
PMID:22902503
Strain, strain background
(M. musculus)
IgHEL PMID:3261841 MD-4
Strain, strain background
(M. musculus)
sHEL PMID:3261841 ML-5
Strain, strain background
(M. musculus)
IgM-/- PMID:9655395
Strain, strain background
(M. musculus)
IgD-/- PMID:8446604
Strain, strain background
(M. musculus)
CD40L-/- PMID:7964465
Strain, strain background
(M. musculus)
Unc93b 3d/3d PMID:16415873
Strain, strain background
(M. musculus)
TLR7-/- PMID:15034168
Strain, strain background
(M. musculus)
BaffTg MMRRC UC Davis RRID:MMRRC_036508-UCD Described in
PMID:15972664
Strain, strain background
(M. musculus)
B6.IgHa The Jackson Laboratory JAX:001317 B6.Cg-Gpi1a
Thy1a Igha/J
Strain, strain background
(M. musculus)
Lyn-/- PMID:9252121
Strain, strain background
(M. musculus)
MB1-Cre PMID:16940357
Strain, strain background
(M. musculus)
MyD88 fl/fl PMCID:PMC2847796
Strain, strain background
(M. musculus)
Nr4a1-/- PMID:7624775 JAX:006187
Biological sample
(Ovis aires)
Sheep Red Blood Cells Rockland R406-0050
Antibody Anti-B220-A647
(rat monoclonal)
BD Pharmingen 557683 (1:200)
Antibody Anti-B220-APC-e780
(rat monoclonal)
eBioscience 47-0452-82 (1:400)
Antibody Anti-B220-FITC
(rat monoclonal)
Tonbo 35–0452 U100 (1:200)
Antibody Anti-B220-Pacific Blue
(rat monoclonal)
Tonbo 75–0452 U100 (1:200)
Antibody Anti-B220-PE
(rat monoclonal)
BD Pharmingen 553090 (1:200)
Antibody Anti-B220-PE-Cy7
(rat monoclonal)
BD Pharmingen 552772 (1:200)
Antibody Anti-B220-PerCP-Cy5.5
(rat monoclonal)
Tonbo 65–0452 U100 (1:200)
Antibody Anti-CD5-APC
(rat monoclonal)
Tonbo 20–0051 U100 (1:100)
Continued on next page
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Continued
Reagent type (species)
or resource Designation Source or reference Identifiers Additional information
Antibody Anti-CD19-PE-Cy7
(rat monoclonal)
Biolegend 115520 (1:150)
Antibody Anti-CD19-PerCP-Cy5.5
(rat monoclonal)
BD Pharmingen 551001 (1:150)
Antibody Anti-CD21-A647
(rat monoclonal)
Biolegend 123424 (1:100)
Antibody Anti-CD21-Pacific Blue
(rat monoclonal)
Biolegend 123414 (1:100)
Antibody Anti-CD23-A647
(rat monoclonal)
Biolegend 101612 (1:200)
Antibody Anti-CD23-FITC
(rat monoclonal)
BD Pharmingen 553138 (1:200)
Antibody Anti-CD23-Pacific Blue
(rat monoclonal)
Biolegend 101616 (1:100)
Antibody Anti-CD23-PE
(rat monoclonal)
BD Pharmingen 553139 (1:200)
Antibody Anti-CD23-PE-Cy7
(rat monoclonal)
eBioscience 25-0232-82 (1:200)
Antibody Anti-CD69-APC
(hamster monoclonal)
Biolegend 104514 (1:100)
Antibody Anti-CD69-PE-Cy7
(hamster monoclonal)
Tonbo 60–0691 U100 (1:100)
Antibody Anti-CD86-Pacific Blue
(rat monoclonal)
Biolegend 105022 (1:100)
Antibody Anti-CD93 (AA4.1)-PE-Cy7
(rat monoclonal)
Biolegend 136506 (1:100
Antibody Anti-CD138-PE
(rat monoclonal)
Biolegend 142504 (1:100)
Antibody Anti-CD138-PE-Cy7
(rat monoclonal)
Biolegend 142513 (1:100)
Antibody Anti-CXCR4-Biotin
(rat monoclonal)
BD Pharmingen 551968 (1:100)
Antibody Anti-ETS1
(rabbit monoclonal)
Epitomics; abcam EPI:3123–1; AB:109212 (1:10,000); concentrated
lot from L.A. Garrett-Sinha
Antibody Anti-Fas-PE-Cy7
(hamster monoclonal)
BD Pharmingen 557653 (1:200)
Antibody Anti-GAPDH
(mouse monoclonal)
EMD Millipore AB2302 (1:2000)
Antibody GL-7-A647
(rat monoclonal)
BD Biosciences 561529 (1:400)
Antibody Anti-IgA-Biotin
(rat monoclonal)
Biolegend 407003 (1:400)
Antibody Anti-IgD (goat
polyclonal serum)
MD Biosciences 2057001 (1:50-1:400)
Antibody Anti-IgD[a]-Biotin
(mouse monoclonal)
BD Pharmingen 553506 (1:300)
Antibody Anti-IgD-APC-e780
(rat monoclonal)
eBioscience 47-5993-80 (1:500)
Antibody Anti-IgD-HRP
(rat monoclonal)
American Research Products 09-1008-4 (1:2000)
Antibody Anti-IgD-Pacific Blue
(rat monoclonal)
Biolegend 405712 (1:300)
Continued on next page
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Continued
Reagent type (species)
or resource Designation Source or reference Identifiers Additional information
Antibody Anti-IgD-PE
(rat monoclonal)
eBioscience 12-5993-82 (1:800)
Antibody Anti-IgG1[a]-Biotin
(mouse monoclonal)
BD Pharmingen 553500 (1:300)
Antibody Anti-IgG1[b]-Biotin
(mouse monoclonal)
BD Pharmingen 553533 (1:300)
Antibody Anti-IgG2a[a]-Biotin
(mouse monoclonal)
BD Biosciences 553502 (1:1000)
Antibody Anti-IgG2a[b]-Biotin
(mouse monoclonal)
BD Biosciences 553504 (1:1000)
Antibody Anti-IgG2c-Biotin
(goat polyclonal)
SouthernBiotech 1079–08 (1:1000)
Antibody Anti-Igk (goat polyclonal) SouthernBiotech 1050–01 1–20 mg/mL
Antibody Anti-Igk-F(ab’)2
(goat polyclonal)
SouthernBiotech 1052–01 1–20 mg/mL
Antibody Anti-Igk-FITC
(goat polyclonal)
SouthernBiotech 1050–02 (1:300)
Antibody Anti-Igk-FITC
(rat monoclonal)
BD Pharmingen 550003 (1:300)
Antibody Anti-Igk-PerCP-Cy5.5
(rat monoclonal)
BD Pharmingen 560668 (1:300)
Antibody Anti-Igl-FITC
(rat monoclonal)
BD Pharmingen 553434 (1:300)
Antibody Anti-Igl-PE
(rat monoclonal)
Biolegend 407307 (1:300)
Antibody Anti-IgM-F(ab’)2
(goat polyclonal)
Jackson ImmunoResearch 115-006-020 1–20 mg/mL
Antibody Anti-IgM-HRP
(goat polyclonal)
SouthernBiotech 1020–05 (1:2000); secondary
for ELISA
Antibody Anti-IgM[a]-Biotin
(mouse monoclonal)
Biolegend 408603 (1:100)
Antibody Anti-IgM[a]-FITC
(mouse monoclonal)
Biolegend 408606 (1:100); (1:400)
for plasma cell
Antibody Anti-IgM[a]-PE
(mouse monoclonal)
BD Pharmingen 553517 (1:100); (1:400)
for plasma cell
Antibody Anti-IgM[b]-Biotin
(mouse monoclonal)
Biolegend 406204 (1:100)
Antibody Anti-IgM[b]-PE
(mouse monoclonal)
Biolegend 406208 (1:100); (1:400)
for plasma cell
Antibody Anti-IgM-APC
(rat monoclonal)
eBioscience 17-5790-82 (1:100)
Antibody Anti-MHC-2-APC
(rat monoclonal)
Tonbo 20–5321 U100 (1:1000)
Antibody Anti-Mouse-IgG(H + L)-HRP
(goat polyclonal)
SouthernBiotech 1031–05 (1:5000); secondary
for western blots
Antibody Anti-Nur77-PE
(mouse monoclonal)
eBioscience 12-5965-80 (1:100)
Antibody Anti-pERK
(rabbit monoclonal)
Cell Signaling Technology 4377S (1:80)
Antibody Anti-pS6
(rabbit monoclonal)
Cell Signaling Technology 4856S (1:100)
Antibody Anti-Rabbit-IgG-APC
(donkey polyclonal)
Jackson ImmunoResearch 711-136-152 (1:100); secondary
for pERK/pS6
Continued on next page
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Continued
Reagent type (species)
or resource Designation Source or reference Identifiers Additional information
Antibody Anti-Rabbit-IgG(H + L)-HRP
(goat polyclonal)
SouthernBiotech 4050–05 (1:5000); secondary
for western blots
Sequence-based reagent Nr4a1 forward primer Elim Biopharm gcctagcactgccaaattg
Sequence-based reagent Nr4a1 reverse primer Elim Biopharm ggaaccagagagcaagtcat
Sequence-based reagent GAPDH forward primer Elim Biopharm aggtcggtgtgaacggatttg
Sequence-based reagent GAPDH reverse primer Elim Biopharm tgtagaccatgtagttgaggtca
Peptide, recombinant
protein
NP-RSA Biosearch N-5054–100 Conj. ratio: 10
Peptide, recombinant
protein
NP-BSA Biosearch N-5050H-100 Conj. ratio: 23
Peptide, recombinant
protein
Streptavidin-HRP SouthernBiotech 7100–05 (1:5000)
Peptide, recombinant
protein
Streptavidin-APC Tonbo 20–4317 U500 (1:100-1:400)
Peptide, recombinant
protein
Streptavidin-Pacific Blue Life Technologies S11222 (1:200)
Peptide, recombinant
protein
Streptavidin-PerCP-Cy5.5 BD Pharmingen 551419 (1:400)
Peptide, recombinant
protein
Streptavidin-FITC Biolegend 405202 (1:100-1:200)
Peptide, recombinant
protein
CXCL12 Peprotech 300-28A
Peptide, recombinant
protein
NP-PE Biosearch N-5070–1 (1:400)
Chemical compound, drug Poly-L-Lysine Sigma P2636-100MG 100 mg/mL in 0.1 M Tris-HCl pH7.3
Chemical compound, drug Poly dA-dT Sigma P0883-50UN 0.2 U/mL in 0.1 M Tris-HCl pH7.3
Chemical compound, drug LPS Sigma L8274
Chemical compound, drug CpG InvivoGen tlrl-1826b
Chemical compound, drug Pam3CSK4 InvivoGen tlrl-pms
Commercial assay, kit Indo-1, AM Life Technologies I-1223 (1:1000)
Commercial assay, kit Live/Dead Fixable Near-IR
Dead Cell Stain Kit
Invitrogen L10119 (1:1000)
Commercial assay, kit ECL Luminol;
Oxidizer Reagents
Perkin Elmer 0RT2751; 0RT2651
Commercial assay, kit 3,3’,5,5’-Tetramethylbenzidine,
Slow Kinetic Form
Sigma T4319-100ML ELISA substrate
Software, algorithm FlowJo FlowJo LLC Version 9.9.4
Software, algorithm Prism GraphPad Version 7.0b
Software, algorithm Canopy Enthought Version 1.4.1.1975
Software, algorithm Binning program in Figure 1F Other Source code provided
in this publication
Other BD Microtainer Capillary
Blood Collector
Fisher 365967
Other PtC-Rhodamine
(DOPC/CHOL Liposomes)
FormuMax F60103F-R (1:1000); used in
PtC-specific B1a staining
Other NuPAGE 4–12%
Bis-Tris Protein Gels
Invitrogen NP0335BOX
Other Immobilon-P PVDF
Membrane
EMD Millipore IPVH00010
Other Assay Plate, 96 Well, No Lid, Vinyl Costar 2595 Used for ELISA
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Mice
Nur77-eGFP mice and Lyn /  mice have been previously described (Chan et al., 1997;
Zikherman et al., 2012). BAFF Tg mice were originally generated in the Nemazee lab, and express
BAFF under the control of the myeloid promoter human CD68 (Gavin et al., 2005) (source: MMRRC
UC Davis). IgD-/- and IgM /  mice were previously described, and the former were generously
shared by Dr. Hassan Jumaa (Lutz et al., 1998; Nitschke et al., 1993). TLR7 / , CD40L / ,
Unc93b13d/3d, Nr4a1 / , and MB1-Cre MyD88fl/fl mice were previously described (Hobeika et al.,
2006; Hou et al., 2008; Lee et al., 1995; Lund et al., 2004; Renshaw et al., 1994; Tabeta et al.,
2006). All strains were backcrossed to the C57BL/6 genetic background for at least six generations.
Mice were used at 5–12 weeks of age for all functional and biochemical experiments unless other-
wise noted. Germ-free (GF) and specific pathogen free (SPF) C57BL/6 mice used for direct compari-
son were purchased from Taconic and Jackson Laboratory and kept in microisolators under GF or
SPF (ISOcage P - Bioexclusion System, Tecniplast) conditions. All GF mice were housed in closed
caging systems and provided with standard irradiated chow diet, acidified water and housed under
a 12 hr light cycle; 7-week-old males mice were used. GF and control mice were generously pro-
vided by Drs. Sergio Baranzini and Anne-Katrin Proebstel at UCSF. All other mice used in our studies
were housed in a specific pathogen free facility at UCSF according to the University Animal Care
Committee and National Institutes of Health (NIH) guidelines.
Antibodies and reagents
Fluorescently-conjugated or biotin-conjugated antibodies to B220, CD5, CD19, CD21, CD23, CD69,
CD86, CD93 (AA4.1), CD95 (Fas), CD138, CXCR4, IgA, IgM, IgM[a], IgM[b], IgD, IgD[a], IgG1[a],
IgG1[b], Igk, Igl, GL-7, MHC Class II, and fluorescently-conjugated streptavidin were from Biole-
gend, eBiosciences, BD Biosciences, Tonbo, or Life Technologies. NP-PE was from Biosearch Tech-
nologies. 100 nm Rhodamine PtC liposomes were from FormuMax. Antibodies for intra-cellular
staining, pErk Ab (clone 194g2) and pS6 Ab (2F9), were from Cell Signaling Technologies, and
Nur77 Ab (clone 12.14) conjugated to PE was from eBioscience. Goat anti-mouse IgM F(ab’)2 was
from Jackson Immunoresearch. Goat anti-mouse Igk and goat F(ab’)2 anti-mouse Igk were from
Southern Biotech. Anti-IgD was from MD Biosciences. CXCR4 ligand (CXCL12/hSDF-1a) was from
Peprotech. LPS (Cat. L8274) was from Sigma. CpG DNA (ODN 1826 Biotin; Cat. tlrl-1826b) and
Pam3CSK4 (Cat. tlrl-pms) were from InvivoGen.
Flow cytometry and data analysis
Cells were stained with indicated antibodies and analyzed on a Fortessa (Becton Dickson) as previ-
ously described (Hermiston et al., 2005). Data analysis was performed using FlowJo (v9.7.6) soft-
ware (Treestar Incorporated, Ashland, OR). Statistical analysis and graphs were generated using
Prism v6 (GraphPad Software, Inc). Figures were prepared using Illustrator CS6 v16.0.0. Median Igk
levels (Figure 1F) were calculated for 200 equally sized ‘bins’ spanning the Nur77-eGFP spectrum
using Canopy v1.4.1 (Enthought); source code is provided, and parameters can be modified to con-
dense any 2D FACS plot for comparisons of multiple samples.
Statistics and replicates
We define biological replicates as independent analyses of cells isolated from different mice of the
same genotype, and we define technical replicates as analyses of cells isolated from the same mouse
and used in the same experiment. When technical replicates were used, we averaged them to calcu-
late a value for the biological replicate. All reported values and statistics correspond to biological
replicates only, and all ‘n’ values reported reflect the number of biological replicates. Wherever MFIs
are directly compared, we collected all samples in a single experiment to avoid potential error that
could arise from fluctuations in our flow cytometers. In some instances, MFI ratios were compiled
from different experiments for statistical purposes, but qualitative findings were consistent experi-
ment to experiment. As our panels reproducibly generated flow plots with well-defined populations,
population sizes were calculated from data compiled from different experiments. When comparing
two groups, we employed Welch’s t test, which is more stringent than Student’s t test and does not
assume that the groups have the same standard deviation. We used paired difference t tests when
studying parameters in allotype-heterozygous mice that are sensitive to cell-extrinsic factors (e.g.
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dose of immunogen or severity of autoimmune disease). When comparing three genotypes (e.g.
receptor levels on WT vs. IgM / vs. IgD /  B cells), we used one-way ANOVA and Tukey’s multiple
comparison test to calculate p values.
Intracellular Nur77, pErk and pS6 staining
Ex vivo or following stimulation, cells were fixed in 2% paraformaldehyde, permeabilized with 100%
methanol, and stained with anti-Nur77, anti-pErk, or anti-pS6 followed by lineage markers and sec-
ondary antibodies if needed.
Intracellular plasma cell staining
Cells were fixed in 2% paraformaldehyde and permeabilized in BD Perm/Wash. Stains for antibody
isotypes and allotypes were prepared in BD Perm/Wash.
Intracellular calcium flux
Cells were loaded with 5 mg/mL Indo-1 AM (Life Technologies) and stained with lineage markers.
Cells were rested at 37 C for 2 min, and Indo-1 fluorescence was measured immediately prior to
stimulation to calculate basal calcium, and for at least two minutes following addition of stimulus.
In vitro B cell stimulation
Splenocytes or lymphocytes were harvested into single cell suspension, subjected to red cell lysis
using ACK buffer, and plated at a concentration of 7.5  105 cells/200 mL in round bottom 96 well
plates in complete RPMI media with stimuli for 18 hours prior to analysis. In vitro cultured cells were
stained using fixable near IR live/dead stain (Life technologies) per manufacturer’s instructions.
ELISA
Serum antibody titers for total IgM, total IgD, anti-dsDNA IgG2a, and NP-specific IgG1 were mea-
sured by ELISA. For total IgM and total IgD, 96-well plates (Costar) were coated with 1 mg/mL anti-
IgM F(ab’)2 (Jackson) or 1 mg/mL anti-IgD (BD 553438), respectively. Sera were diluted serially, and
total IgM and total IgD were detected with anti-IgM-biotin (eBioscience) and SA-HRP (Southern Bio-
tech) or anti-IgD-HRP (American Research Products). dsDNA plates were generated by serially coat-
ing plates with 100 mg/mL poly-L-lysine (SigmaAldrich) and 0.2 U/mL poly dA-dT (SigmaAldrich) in
0.1 M Tris-HCL pH 7.6. Sera were diluted serially on dsDNA plates, and autoantibodies were
detected with IgG2[a]-biotin, IgG2a[b]-biotin, and SA-HRP. NP plates were generated by coating 96-
well plates with 1 mg/mL NP-BSA (Biosearch, conjugation ratio 23) in PBS. Sera from NP-RSA immu-
nized and unimmunized mice were diluted serially, and NP-specific IgG1 was detected with IgG1[a]-
biotin, IgG1[b]-biotin, and SA-HRP. All ELISA plates were developed with TMB (Sigma) and stopped
with 2N sulfuric acid. Absorbance was measured at 450 nm. For total IgM, total IgD, and dsDNA
IgG2a, OD values or OD ratios were calculated and displayed. For NP-specific IgG1, titers were cal-
culated at OD = 0.2 and normalized such that the average IgG1[a]/IgG1[b] ratio in immunized Balb/
c-C57BL/6 F1 mice equals 1.0.
B cell purification and western blots
Splenic B cells were purified by negative selection with a MACS kit according to manufacturer’s pro-
tocol (Miltenyi Biotech, cat# 130-090-862). Purified B cells were lysed in 2N 4X SDS and boiled at
95 C for 5 min. 500,000 cells per lane were loaded onto NuPAGE 4–12% Bis-Tris gels (Invitrogen
NP0335), run for 50 min at 200V, and transferred onto PVDF membranes using an XCell II Blot Mod-
ule (Invitrogen). Membranes were blocked with 3% BSA. Proteins were detected with rabbit mono-
clonal anti-Ets1 (Epitomics, custom lot provided by Lee Ann Garrett-Sinha), mouse anti-mouse
GAPDH (Santa Cruz Biotechnology 32233), and HRP-conjugated secondary antibodies goat anti-rab-
bit IgG (H + L) and goat anti-mouse IgG (H + L) (SouthernBiotech). Membranes were developed with
Western Lightning Plus ECL (Perkin Elmer 0RT2651 and 0RT2751) and imaged using a ChemiDoc
Touch Imaging System (Bio-Rad). Quantifications were performed using Image Lab v. 5.2.14 (Bio-
Rad).
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Immunizations
Mice were immunized i.p. with 200 uL of 10% sheep red blood cells (Rockland R406-0050) diluted in
PBS. Mice were sacrificed 5 days after immunization, and serum and spleens were harvested. Mice
were immunized i.p. with 100 ug of NP-conjugated rabbit serum album (NP-RSA, Biosearch N-5054–
10, conjugation ratio 10) prepared in PBS with Alhydrogel 1% adjuvant (Accurate Chemical and Sci-
entific Corp. 21645-51-2). NP-RSA immunized mice were sacrificed 7–8 days following immunization,
and serum and spleens were harvested. To ensure that our calculated values accurately reflect the
magnitude and variability of immune responses induced by immunization, we analyzed all mice that
had larger plasma cell and germinal center compartments than unimmunized mice. One IgM+/ 
mouse immunized with SRBCs (Figure 7E–F) was excluded because it did not display an expanded
plasma cell compartment; no other mice were excluded from analysis.
Quantitative PCR
Splenocytes were lysed in TRIzol (Invitrogen) and stored at  80 C. cDNA was prepared using a
SuperScriptIII kit (Invitrogen). Quantitative PCR reactions were run on a QuantStudio 12K Flex ther-
mal cycler (Applied Biosystems) with FastStart Universal SYBR Green Master Mix (Roche). Nr4a1 (for-
ward: gcctagcactgccaaattg; reverse: ggaaccagagagcaagtcat) and GAPDH (forward:
aggtcggtgtgaacggatttg; reverse: tgtagaccatgtagttgaggtca) primers were used at 250 nM each.
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